Explore the words cloud of the PDZnet project. It provides you a very rough idea of what is the project "PDZnet" about.
The following table provides information about the project.
Coordinator |
KOBENHAVNS UNIVERSITET
Organization address contact info |
Coordinator Country | Denmark [DK] |
Project website | http://pdznet.eu/ |
Total cost | 3˙733˙514 € |
EC max contribution | 3˙733˙514 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2015 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2016 |
Duration (year-month-day) | from 2016-09-01 to 2020-08-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | KOBENHAVNS UNIVERSITET | DK (KOBENHAVN) | coordinator | 580˙163.00 |
2 | NOVO NORDISK A/S | DK (BAGSVAERD) | participant | 580˙163.00 |
3 | UPPSALA UNIVERSITET | SE (UPPSALA) | participant | 527˙318.00 |
4 | SYSTASY BIOSCIENCE GMBH | DE (MUNCHEN) | participant | 456˙204.00 |
5 | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | FR (PARIS) | participant | 307˙418.00 |
6 | CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE | FR (ILLKIRCH GRAFFENSTADEN) | participant | 262˙875.00 |
7 | INSTITUT PASTEUR | FR (PARIS CEDEX 15) | participant | 262˙875.00 |
8 | UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA | IT (ROMA) | participant | 258˙061.00 |
9 | EUROPEAN MOLECULAR BIOLOGY LABORATORY | DE (HEIDELBERG) | participant | 249˙216.00 |
10 | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN | DE (FRANKFURT AM MAIN) | participant | 249˙216.00 |
PDZnet will create an innovative European PhD training network focusing on unraveling PDZ domain-mediated signaling networks. The emphasis will be on signaling nodes essential for the development of cancer and diseases of the nervous system, conditions that affect millions of Europeans and are major societal challenges. PDZ domains are protein and lipid recognizing modules that play a central role in trafficking and organizing diverse cell signaling assemblies, thereby allowing information to be transmitted from receptors, ion channels and transporters in the cell membrane. PDZ domain mediated interactions are emerging as conceptually novel and promising drug targets, with exciting opportunities for the development of novel therapies, especially within cancer and brain diseases. We will establish a European multidisciplinary platform integrating a plethora of complementary life science disciplines that range from chemical development of inhibitors to studies in live animals. The network encompasses 8 academic and 2 industrial beneficiaries as well as one industrial and one academic partner, which are all committed to promote frontline research, innovation and educational activities within the study of PDZ domain-mediated signal transduction pathways related to brain diseases and cancer. This interdisciplinary network will establish an outstanding training opportunity for Early Stage Researchers, who will be integrated in projects unraveling intracellular PDZ domain interactomes to provide pertinent information for discovering drug-related interactions. In a comprehensive and integrated training effort, involving a combination of scientific and transferable skills, the students will receive an interdisciplinary, intersectoral and innovative doctoral training from experienced industrial and academic leaders in well-reputed European Institutions.
CDE plan | Documents, reports | 2020-03-20 16:08:19 |
PDZnet website | Websites, patent fillings, videos etc. | 2020-03-20 16:08:19 |
Take a look to the deliverables list in detail: detailed list of PDZnet deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Antonio Coluccia, Giuseppe La Regina, Valentina Naccarato, Marianna Nalli, Viviana Orlando, Stefano Biagioni, Maria Laura De Angelis, Marta Baiocchi, Candice Gautier, Stefano Gianni, Fiorella Di Pastena, Laura Di Magno, Gianluca Canettieri, Addolorata Maria Luce Coluccia, Romano Silvestri Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents published pages: , ISSN: 1948-5875, DOI: 10.1021/acsmedchemlett.8b00532 |
ACS Medicinal Chemistry Letters | 2020-03-20 |
2016 |
Muna L Hilal, Maité M Moreau, Claudia Racca, Vera L Pinheiro, Nicolas H Piguel, Marie-Josée Santoni, Steve Dos Santos Carvalho, Jean-Michel Blanc, Yah-Se K Abada, Ronan Peyroutou, Chantal Medina, Hélène Doat, Thomas Papouin, Laurent Vuillard, Jean-Paul Borg, Rivka Rachel, Aude Panatier, Mireille Montcouquiol, Stéphane H R Oliet, Nathalie Sans Activity-Dependent Neuroplasticity Induced by an Enriched Environment Reverses Cognitive Deficits in Scribble Deficient Mouse published pages: 5635-5651, ISSN: 1047-3211, DOI: 10.1093/cercor/bhw333 |
Cerebral Cortex 27/12 | 2020-03-20 |
2018 |
Candice Gautier, Louise Laursen, Per Jemth, Stefano Gianni Seeking allosteric networks in PDZ domains published pages: , ISSN: 1741-0126, DOI: 10.1093/protein/gzy033 |
Protein Engineering, Design and Selection | 2020-03-20 |
2017 |
Eric Bailly, Alexandra Walton, Jean-Paul Borg The planar cell polarity Vangl2 protein: From genetics to cellular and molecular functions published pages: , ISSN: 1084-9521, DOI: 10.1016/j.semcdb.2017.10.030 |
Seminars in Cell & Developmental Biology | 2020-03-20 |
2017 |
Tianliang Sun, Lida Yang, Harmandeep Kaur, Jenny Pestel, Mario Looso, Hendrik Nolte, Cornelius Krasel, Daniel Heil, Ramesh K. Krishnan, Marie-Josée Santoni, Jean-Paul Borg, Moritz Bünemann, Stefan Offermanns, Jakub M. Swiercz, Thomas Worzfeld A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib published pages: 199-215, ISSN: 0021-9525, DOI: 10.1083/jcb.201602002 |
The Journal of Cell Biology 216/1 | 2020-03-20 |
2018 |
Madeline N. Hayes, Karin McCarthy, Alexander Jin, Mariana L. Oliveira, Sowmya Iyer, Sara P. Garcia, Sivasish Sindiri, Berkley Gryder, Zainab Motala, G. Petur Nielsen, Jean-Paul Borg, Matt van de Rijn, David Malkin, Javed Khan, Myron S. Ignatius, David M. Langenau Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma published pages: 414-427.e6, ISSN: 1934-5909, DOI: 10.1016/j.stem.2018.02.002 |
Cell Stem Cell 22/3 | 2020-03-20 |
2018 |
Laura Polivka, Smail Hadj-Rabia, Elodie Bal, Stéphanie Leclerc-Mercier, Marine Madrange, Yamina Hamel, Damien Bonnet, Stéphanie Mallet, Hubert Lepidi, Caroline Ovaert, Patrick Barbet, Christophe Dupont, Bénédicte Neven, Arnold Munnich, Lisa M. Godsel, Florence Campeotto, Robert Weil, Emmanuel Laplantine, Sylvie Marchetto, Jean-Paul Borg, William I. Weis, Jean-Laurent Casanova, Anne Puel, Kathl Epithelial barrier dysfunction in desmoglein-1 deficiency published pages: , ISSN: 0091-6749, DOI: 10.1016/j.jaci.2018.04.007 |
Journal of Allergy and Clinical Immunology | 2020-03-20 |
2017 |
Amandine Cartier-Michaud, Anne-Laure Bailly, Stéphane Betzi, Xiaoli Shi, Jean-Claude Lissitzky, Ana Zarubica, Arnauld Sergé, Philippe Roche, Adrien Lugari, Véronique Hamon, Florence Bardin, Carine Derviaux, Frédérique Lembo, Stéphane Audebert, Sylvie Marchetto, Bénédicte Durand, Jean-Paul Borg, Ning Shi, Xavier Morelli, Michel Aurrand-Lions Genetic, structural, and chemical insights into the dual function of GRASP55 in germ cell Golgi remodeling and JAM-C polarized localization during spermatogenesis published pages: e1006803, ISSN: 1549-1277, DOI: 10.1371/journal.pgen.1006803 |
PLOS Genetics 13/6 | 2020-03-20 |
2017 |
Candice Gautier, Lorenzo Visconti, Per Jemth, Stefano Gianni Addressing the role of the α-helical extension in the folding of the third PDZ domain from PSD-95 published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-017-12827-0 |
Scientific Reports 7/1 | 2020-03-20 |
2018 |
Jia Yuan, Wenbo Deng, Jeeyeon Cha, Xiaofei Sun, Jean-Paul Borg, Sudhansu. K. Dey Tridimensional visualization reveals direct communication between the embryo and glands critical for implantation published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-018-03092-4 |
Nature Communications 9/1 | 2020-03-20 |
2017 |
Avais M. Daulat, Jean-Paul Borg Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment published pages: 113-125, ISSN: 2405-8033, DOI: 10.1016/j.trecan.2017.01.001 |
Trends in Cancer 3/2 | 2020-03-20 |
2018 |
Concetta Saponaro, Sara Sergio, Antonio Coluccia, Maria De Luca, Giuseppe La Regina, Luca Mologni, Valeria Famiglini, Valentina Naccarato, Daniela Bonetti, Candice Gautier, Stefano Gianni, Daniele Vergara, Michel Salzet, Isabelle Fournier, Cecilia Bucci, Romano Silvestri, Carlo Gambacorti Passerini, Michele Maffia, Addolorata Maria Luce Coluccia β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy published pages: 3301-3316, ISSN: 0950-9232, DOI: 10.1038/s41388-018-0170-y |
Oncogene 37/24 | 2020-03-20 |
2019 |
Antonio Coluccia, Giuseppe La Regina, Valentina Naccarato, Marianna Nalli, Viviana Orlando, Stefano Biagioni, Maria Laura De Angelis, Marta Baiocchi, Candice Gautier, Stefano Gianni, Fiorella Di Pastena, Laura Di Magno, Gianluca Canettieri, Addolorata Maria Luce Coluccia, Romano Silvestri Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents published pages: , ISSN: 1948-5875, DOI: 10.1021/acsmedchemlett.8b00532 |
ACS Medicinal Chemistry Letters | 2020-03-20 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PDZNET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PDZNET" are provided by the European Opendata Portal: CORDIS opendata.